Patent US4814176A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4814176A Expired / Lapsed US ⏱️ 0.0 years remaining

Sustained release preparation

Assignee: Teijin Ltd
•
Filing: 1986-01-10
•
Granted: 1989-03-21
•
Expires: 2006-01-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A sustained release preparation comprising: (a) chitin, chitosan, or a mixture thereof (b) anionic polymer compounds such as those having a carboxyl group, a sulfonic acid group, or a group capable of providing the same, and (c) pharmaceutically active agents. This sustained release preparation can provide the desired sustained-release or dissolution of the pharmaceutically active agents in human organs irrespective of the acidity (i.e., pH conditions) therein.

Inventors

  • 👤 Yuji Makino
  • 👤 Hideo Matugi
  • 👤 Yoshiki Suzuki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 09:39
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/205; A61K9/2027; A61K9/2054; A61K9/48; A61K9/4841; A61K9/4866

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 60 words
A sustained release preparation consisting essentially of: (a) chitin, chitosan, or a mixture thereof; (b) at least one anionic polymer compound, and (c) a pharmaceutically effective amount of at least one pharmaceutically active agent, wherein (b) is present in said preparation in a ratio of from 10 to b 1,000 parts by weight per 100 parts by weight of (a).
Claim 2
Dependent Claim 60 words
A sustained release preparation consisting essentially of: (a) chitin, chitosan, or a mixture thereof; (b) at least one anionic polymer compound, and (c) a pharmaceutically effective amount of at least one pharmaceutically active agent, wherein (b) is present in said preparation in a ratio of from 10 to b 1,000 parts by weight per 100 parts by weight of (a).
Claim 3
Dependent Claim 32 words
A sustained release preparation as claimed in claim 1, wherein the anionic polymer compounds are those having a carboxyl group, a sulfonic acid group, or a group capable of providing the same.
Claim 4
Dependent Claim 28 words
A sustained release preparation as claimed in claim 1, wherein the anionic polymer compounds are those having a carboxyl group or a group capable of providing the same.
Claim 5
Dependent Claim 70 words
A sustained release preparation as claimed in claim 1, wherein the anionic polymer compound is at least one compound selected from the group consisting of carboxyvinyl polymer and the salts thereof, polyacrylic acid and the salts thereof, methoxyethylene-maleic anhydride copolymer and the hydrolyzates thereof, methacrylic acid-methyl methacrylate copolymer, partial methyl esters of vinyl acetate-maleic anhydride copolymer, vinyl acetate-crotonic acid copolymer, carboxymethyl cellulose, alginic acid, pectin, hyaluronic acid, and poly-L-glutamic acid.
Claim 6
Dependent Claim 58 words
A sustained release preparation as claimed in claim 1, wherein the pharmaceutically active agent is at least one member selected from the group consisting of antipyretic, analgesic, or antiphlogistics, antiarrhythmics, hypotensors, vasodilators, antiarteriosclerotics, agents for circulatory systems, antitussive expectorants, ulcer preventives, enzyme preparations, antimalignants, chemotherapeutic agents, antiphlogistic steroid agents, antihistamine agents, local anesthetic agents, and mouth disinfection agents.
Claim 7
Dependent Claim 23 words
A sustained release preparation as claimed in claim 1 in the form of tablets, granules, grains, powders, dental cones, films, or hard capsules.
Claim 8
Dependent Claim 22 words
A method for administering a sustained release preparation according to claim 1 whereby the pharmaceutically active agent contained therein is gradually released.
Claim 9
Dependent Claim 16 words
A method as claimed in claim 7, wherein the preparation is perorally, intraorally or intranasally administered.

References Cited (Backward Citations)

US4472376A Cited
US4404183A Cited
US4606909A Cited
US4642111A Cited
US4501835A Cited
US4536495A Cited
US4572832A Cited
US4681755A Cited
US4666705A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-20 1992-09-19 1993-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-20 1996-09-19 1997-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-20 2000-09-19 2001-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag